Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL
Exciting current CLL trials taking place in the UK
Homeless tumour cells in CLL
Can ibrutinib be used as a first-line treatment in CLL?
The current status of CLL treatment and how clinical practice will change